Laparoscopic Surgery for Bladder Cancer Shows Good Results
By HospiMedica International staff writers Posted on 31 Dec 2014 |
Long-term survival rates following laparoscopic radical cystectomy (LRC) for bladder cancer are comparable to those of open surgery, according to a new study.
Researchers at Université Libre de Bruxelles (ULB; Belgium), the University of Heidelberg, (Germany), and other institutions participating in a multicenter European cohort study prospectively enrolled 503 patients who underwent LRC for bladder cancer between 2000 and 2013. The data were retrospectively analyzed to explore peri- and post-operative characteristics, evaluate recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). The outcomes were also stratified according to tumor stage, lymph node (LN) involvement, and surgical margin status.
The results showed that minor complications occurred in 39% of the cohort and major complications in a further 17%. In all, 10 (2%) postoperative deaths were recorded. After five years, 66% of patients had no signs of bladder cancer recurrence, and among those followed for 10 years, 62% had no signs of recurrence. Upon analysis, tumor stage and LN involvement were significant predictors of RFS, CSS, and OS, and positive margins were significant predictors of RFS and CSS. The study was published on December 18, 2014, in BJU International.
“These results are vital to globally evaluate the efficacy of this procedure. They suggest that a laparoscopic approach to bladder cancer, when performed correctly, can be as safe as open surgery with regards to cancer control, though maintaining the benefits of a minimally invasive approach,” said lead author Simone Albisinni, MD, of ULB. “In spite of the technical difficulty and the need for a learning curve, these findings support the use of a laparoscopic approach for the management of bladder cancer.”
Open radical cystectomy (ORC, the removal of the bladder though open surgery) is the treatment of choice for muscle invasive and high-risk non-muscle invasive bladder cancer; however, the surgery can lead to serious complications. LRC could serve an attractive treatment option for selected candidates who have localized muscle-invasive bladder cancer, with the main advantages being reduced blood loss, leading to improved recovery and shorter hospital stays after the procedure.
Related Links:
Université Libre de Bruxelles
University of Heidelberg
Researchers at Université Libre de Bruxelles (ULB; Belgium), the University of Heidelberg, (Germany), and other institutions participating in a multicenter European cohort study prospectively enrolled 503 patients who underwent LRC for bladder cancer between 2000 and 2013. The data were retrospectively analyzed to explore peri- and post-operative characteristics, evaluate recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). The outcomes were also stratified according to tumor stage, lymph node (LN) involvement, and surgical margin status.
The results showed that minor complications occurred in 39% of the cohort and major complications in a further 17%. In all, 10 (2%) postoperative deaths were recorded. After five years, 66% of patients had no signs of bladder cancer recurrence, and among those followed for 10 years, 62% had no signs of recurrence. Upon analysis, tumor stage and LN involvement were significant predictors of RFS, CSS, and OS, and positive margins were significant predictors of RFS and CSS. The study was published on December 18, 2014, in BJU International.
“These results are vital to globally evaluate the efficacy of this procedure. They suggest that a laparoscopic approach to bladder cancer, when performed correctly, can be as safe as open surgery with regards to cancer control, though maintaining the benefits of a minimally invasive approach,” said lead author Simone Albisinni, MD, of ULB. “In spite of the technical difficulty and the need for a learning curve, these findings support the use of a laparoscopic approach for the management of bladder cancer.”
Open radical cystectomy (ORC, the removal of the bladder though open surgery) is the treatment of choice for muscle invasive and high-risk non-muscle invasive bladder cancer; however, the surgery can lead to serious complications. LRC could serve an attractive treatment option for selected candidates who have localized muscle-invasive bladder cancer, with the main advantages being reduced blood loss, leading to improved recovery and shorter hospital stays after the procedure.
Related Links:
Université Libre de Bruxelles
University of Heidelberg
Latest Surgical Techniques News
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices